Dr. Jon Christopher Pineda Orlino, MD

Dr. Orlino practices at Bay Area Surgical Specialist Services in Walnut Creek, California.

Dr. Orlino's NPI, 1265963789, was assigned on March 26, 2017. Dr. Orlino graduated from Georgetown University School Of Medicine in 2017. Dr. Orlino holds California license A176815.

Dr. Orlino's primary practice is Bay Area Surgical Specialist Services, at 460 N Wiget Ln, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (202) 815-3665.

Dr. Orlino's primary practice is Bay Area Surgical Specialist Services in Walnut Creek, California. Dr. Orlino is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Orlino to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orlino practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Orlino's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Orlino is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Orlino's licenses on file in 2 states: California and Missouri.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Orlino treats.

CMS data shows 1,218 Medicare services from Dr. Orlino across 16 procedure codes in 2024, for 410 Medicare patients. Medicare paid $147,330 for them.

CMS counts 410 Medicare patients who saw Dr. Orlino in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 4.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orlino's median patient age at 72, with 47% women.

In 2024, Dr. Orlino wrote 203 Medicare Part D claims for 97 patients. 79% of them were for generic drugs. CMS names the drug for 190 of them, across 8 drugs with 11 or more claims each, at $34,191 in total drug cost. In 2023, CMS named 123 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Orlino for performance year 2024, reported individually. Dr. Orlino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orlino as offering telehealth. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Orlino, more than 72% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Orlino in 2022. Dr. Orlino's most frequent co-authors are Kevin Y. Pei, MD and Matthew Russell Smeds, MD.

CMS Open Payments shows 58 general payments to Dr. Orlino from 14 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 68% of the total. Medtronic, Inc. paid the most, $1,930.

Dr. Orlino graduated from Georgetown University School Of Medicine in 2017.

Dr. Orlino is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.